National Patient Safety Awareness Week (March 3rd-9th)
By: Alere Staff
Publication Date: Sun, 03/03/2013
March 3rd-9th is National Patient Safety Awareness week. You may be wondering what you can do to improve your safety while taking warfarin (brand name Coumadin® medication). One solution is simply testing your blood at home. As a self-tester, you will continue to see your regular doctor but instead of going to the lab to have your blood tested, you simply test your blood at home to get your INR test result.
This month would be a good time to discuss with your doctor your desire to join the tens of thousands of patients in the United States who, with the support and a prescription from their doctor, are testing their own blood with a simple, small finger stick sample of blood and a reliable home monitor.
How can testing your blood at home improve your safety?
Testing at home allows you to test your blood more often. More frequent testing has been proven to increase the time patients spend in their target range.1 In fact, an observation of over 29,000 self-testing patients found that patients who tested their blood weekly were in range 74% of the time!1 You can increase your safety while taking warfarin by testing your INR weekly with a home INR monitor.
Make a note to talk to your doctor this month to share your desire to improve your safety by testing more often at home. If you and your doctor decide weekly testing is right for you, you could increase the time your INR is within your target range.1
Weekly home INR testing is a covered benefit of Medicare and many private insurance companies. Your doctor will need to support your request by writing a prescription for home testing. We can help arrange for in person training as well as submitting your request to your insurance company to cover some or all your costs.
Call Alere at 1.800.504.4032 to ask about testing your INR in the comfort and privacy of your home.
- Ansell, J. March 2012. Patient Self-Testing: Real-World Experience Within a Comprehensive Support Service Represents a New Standard of Care, Attaining High Quality Anticoagulation Control. Poster presented at: American College of Cardiology.